Carlos Navas
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Collaborative Latin American Imaging Network In Neuroimmunology Research (BRAIMS): Rationale, Structure, Challenges, and Future Directions.
Journal: Multiple sclerosis and related disorders
Published: April 10, 2026
Multiple sclerosis expert patient program in Central America: changes in quality of life and lifestyle habits.
Journal: Neurodegenerative disease management
Published: December 30, 2025
Comparative analysis of AQP4-IgG-positive and AQP4-IgG-negative NMOSD: A multicenter study in Latin America.
Journal: Multiple sclerosis and related disorders
Published: July 24, 2025
Recommendations for essential medicines for multiple sclerosis in low-resource settings.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 01, 2025
Multiple Sclerosis Care in Latin America.
Journal: International journal of MS care
Published: March 13, 2025
Latin American RAND/UCLA modified Delphi consensus recommendations for management and treatment of adult MOGAD patients in clinical practice.
Journal: Multiple sclerosis and related disorders
Published: January 06, 2025
Recommendations on NMOSD treatment in Latin America: Utilizing consensus-based RAND/UCLA methodology.
Journal: Multiple sclerosis and related disorders
Published: October 07, 2024
Core data set for real world data in multiple sclerosis: customization for latin america from a global task force recommendation
Journal: Revista de neurologia
Published: March 19, 2024
Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs.
Journal: Multiple sclerosis and related disorders
Published: January 08, 2023
Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 01, 2022
Therapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America.
Journal: Multiple sclerosis and related disorders
Published: August 03, 2022
All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: Yes.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 02, 2022
Last Updated: 09/26/2026